SXI shareholder plans NYSE sale of 50 shares

Thomas Chorman filed to sell 50 shares of SXI common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $15,278.00 and an anticipated sale date of 08/03/2026.

Rhea-AI Filing Summary

Thomas Chorman filed to sell 50 shares of SXI common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $15,278.00 and an anticipated sale date of 08/03/2026. These shares were acquired via restricted stock vesting from the issuer as compensation on 10/26/2024.

Over the prior three months, Chorman sold 50 shares of common stock on 06/01/2026 for $13,641.00 and another 50 shares on 07/01/2026 for $17,775.50.

Key Figures

Shares to be sold: 50 shares Aggregate market value: $15,278.00 Prior sale 1: 50 shares for $13,641.00 +2 more

5 metrics

Shares to be sold 50 shares Planned NYSE sale reported with anticipated date 08/03/2026

Aggregate market value $15,278.00 Value associated with the 50 shares planned for sale

Prior sale 1 50 shares for $13,641.00 Common stock sale on 06/01/2026

Prior sale 2 50 shares for $17,775.50 Common stock sale on 07/01/2026

Restricted stock vesting date 10/26/2024 Date the 50 compensation shares vested from the issuer

Key Terms

restricted stock vesting, aggregate market value, compensation

3 terms

restricted stock vesting financial

"Common | 10/26/2024 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

aggregate market value financial

"50 | 15278.00 | 12114922 | 08/03/2026 | NYSE"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

compensation financial

"50 | 10/26/2024 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is Thomas Chorman planning for SXI?

Thomas Chorman plans to sell 50 shares of SXI common stock on the NYSE, with an aggregate market value of $15,278.00 and an anticipated sale date of 08/03/2026.

How did Thomas Chorman acquire the SXI shares being sold?

The 50 shares of SXI common stock were acquired through restricted stock vesting from the issuer as compensation on 10/26/2024, rather than through an open-market purchase.

What SXI shares has Thomas Chorman sold in the past 3 months?

In the past three months, Thomas Chorman sold 50 shares of SXI on 06/01/2026 for $13,641.00 and another 50 shares on 07/01/2026 for $17,775.50.

Through which broker will the planned SXI share sale be executed?

The planned sale of 50 SXI shares is to be executed through Fidelity Brokerage Services LLC, with the transaction expected to occur on the NYSE around 08/03/2026.

What is the aggregate market value of the SXI shares to be sold?

The 50 SXI common shares covered by this notice have an aggregate market value of $15,278.00, based on the figures reported for the planned NYSE sale around 08/03/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 01:20 PM Accepted by SEC EDGAR 08/03/2026 - 01:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001248847
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	STANDEX INTERNATIONAL CORP/DE/
SEC File Number	001-07233
Address of Issuer	23 KEEWAYDIN DRIVE SUITE 300 SALEM NEW HAMPSHIRE 03079
Phone	603-893-9701
Name of Person for Whose Account the Securities are To Be Sold	CHORMAN THOMAS E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Salem NH 03079	50	15278.00	12114922	08/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/26/2024	Restricted Stock Vesting	Issuer			50	10/26/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Thomas Chorman 23 Keewaydin Drive Salem NH 03079	Common	06/01/2026	50	13641.00
Thomas Chorman 23 Keewaydin Drive Salem NH 03079	Common	07/01/2026	50	17775.50

144: Remarks and Signature

Remarks
Date of Notice	08/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Tyler Johnson, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Thomas Chorman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)